| IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation (NCT05339581) | RenJi Hospital | 2022-05-20 |
| HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT (NCT05166239) | Peking University | 2022-01-10 |
| Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome (NCT05123326) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-10-15 |
| Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring (NCT06005883) | Keimyung University Dongsan Medical Center | 2021-04-10 |
| Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis (NCT04055389) | Jonathan Stine | 2021-01-01 |
| Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients (NCT05012501) | The Affiliated Hospital of Qingdao University | 2020-09-01 |
| SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT (NCT04387695) | First Affiliated Hospital of Zhejiang University | 2020-04-30 |
| Safety of Anticoagulant Therapy After Endoscopic Treatment (NCT04976543) | Qilu Hospital of Shandong University | 2020-02-01 |
| Neo-TACE-HAIC for PVTT-HCC (NCT04181931) | Sun Yat-sen University | 2019-12-16 |
| The Effect of Rifaximin on Portal Vein Thrombosis (NCT03631147) | Shanghai Zhongshan Hospital | 2018-09-03 |
| EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications (NCT03477149) | Assistance Publique - Hôpitaux de Paris | 2018-03-30 |
| Vienna Vascular Liver Disease Study (NCT03541057) | Medical University of Vienna | 2017-12-12 |
| TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis (NCT02485184) | Air Force Military Medical University, China | 2017-07-09 |
| Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis (NCT03009461) | Peking University | 2017-06-01 |
| Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma (NCT03902678) | Mansoura University | 2017-05-11 |
| Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS (NCT03031717) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2017-01-01 |
| Indicators Affecting PVT Recanalization (NCT07473375) | Shanghai Zhongshan Hospital | 2017-01-01 |
| Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis (NCT04173429) | Qilu Hospital of Shandong University | 2017-01-01 |
| Chances in Portal System Flow After Two Bariatric Procedures (NCT02733770) | Assuta Medical Center | 2017-01-01 |
| A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation (NCT06513780) | Ru-zhou Cai | 2016-01-01 |
| The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT (NCT02630095) | Shanghai Zhongshan Hospital | 2015-12-01 |
| Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study (NCT02627053) | Università degli Studi dell'Insubria | 2015-12-01 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism (NCT02585713) | Academic and Community Cancer Research United | 2015-11-20 |
| TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV (NCT02853526) | Zaibo Jiang | 2015-07-01 |
| The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis (NCT02398357) | Shanghai Zhongshan Hospital | 2015-03-01 |
| Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis (NCT02250391) | Nihon Pharmaceutical Co., Ltd | 2014-09-01 |
| Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV (NCT03201367) | Zagazig University | 2014-05-01 |
| Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis (NCT03193502) | Sherief Abd-Elsalam | 2014-05-01 |
| A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis (NCT05541562) | The Affiliated Hospital of Qingdao University | 2013-01-01 |
| Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis (NCT05132192) | Elvan Onur Kirimker | 2013-01-01 |
| Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery (NCT01690715) | Hospital Sirio-Libanes | 2012-07-01 |
| Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver (NCT01631877) | Institute of Liver and Biliary Sciences, India | 2012-06-01 |
| Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry (NCT01470547) | University of Roma La Sapienza | 2012-04-01 |
| Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding (NCT01095185) | Juan A. Arnaiz | 2010-11-01 |
| TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis (NCT01556282) | Emory University | 2009-03-01 |
| Anticoagulation Post Laparoscopic Splenectomy (NCT00769873) | University of Alberta | 2006-10-01 |
| Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes (NCT07252570) | Centre Hospitalier Universitaire de Nice | 2004-04-08 |
| Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis (NCT02526303) | Air Force Military Medical University, China | |